Quest Diagnostics to acquire 2 laboratories co-owned by Baylor Scott &White, US Oncology

Madison, N.J.-based Quest Diagnostics signed definitive agreements to acquire two laboratory operations in Lewisville, Texas: Med Fusion and ClearPoint Diagnostic Laboratories, according to StreetInsider.com.

Advertisement

Once the transaction closes, Quest will become the preferred provider of advanced oncology diagnostics for The Woodlands, Texas-based The US Oncology Network, one of the five co-owners of the two laboratories.

Quest will also become the preferred provider for a full range of inpatient and outpatient diagnostic services for 12 hospitals within the Dallas-based Baylor Scott & White health system. BS&W is also one of the co-owners of the laboratory operations.

Officials expect to close the transaction within the third quarter of 2017, subject to customary regulatory approval.

More articles on transactions and valuations:
ProMedica’s acquisition of Michigan health center delayed until January
18 recent hospital transactions and partnerships
Perimeter Healthcare acquires Beacon Children’s Hospital

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.